DARK SECRETS: Pfizer - The Real Truth

Pfizer's Atirmociclib Held Off Breast Cancer Progression for 9.4 Months Versus 6.6 After CDK4/6 Drugs Stopped Working

Atirmociclib delayed advanced breast cancer progression by 9.4 months vs. 6.6 in a Phase 2 trial after CDK4/6 drugs. Survival data are not yet available.

Medical Daily · 9h ago

COVID Vaccine Skeptic Alex Berenson's Lawsuit over Termination of His Twitter Account Thrown Out

From Berenson v. Gottlieb, decided yesterday by Judges Pierre Leval, Richard Wesley, and Joseph Bianco: Plaintiff-Appellant Alex Berenson … is… The post COVID Vaccine Skeptic Alex Berenson's Lawsuit over Termination of His Twitter Account Thrown Out appeared first on Reason Magazine.

Reason · Oct 21

Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs

Biotech and pharma stocks, tracked by the iShares Biotechnology ETF, have shown relative strength amid the tech sell-off, with Eli Lilly and Pfizer standing out as top performers.

MarketBeat · Oct 21

Tukysa Wins FDA Nod for First-Line HER2-Positive Breast Cancer Maintenance After Trial Showed 8.6-Month Longer Median Disease Control

FDA approves Tukysa with Herceptin and Perjeta as maintenance therapy for metastatic HER2-positive breast cancer. Here is who qualifies and the tradeoffs.

Medical Daily · Oct 8

HRSA Names 10 Drugmakers and 21 Drugs for 340B Rebate Pilot as Hospitals Weigh Options Before January Launch

HRSA approved 10 drugmakers and 21 drugs, including Eliquis and Jardiance, for its 340B rebate pilot starting Jan. 1 as hospitals weigh legal options.

Medical Daily · Oct 5

3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note

With the 10-year Treasury yielding around 5.3%, Pfizer, Energy Transfer, and Plains All American offer stocks under $30 with dividend yields between 6% and 7%.

MarketBeat · Oct 3

Florida Sues Pfizer Over Claims It Hid Myocarditis and Miscarriage Risks as COVID Vaccine Sales Hit $80B

Florida alleges Pfizer and Albert Bourla misled consumers about COVID-19 vaccine risks, pregnancy and transmission while Pfizer rejects the claim

International Business Times UK · Oct 2

Californians Deserve Greater Drug Transparency

California prescription drug transparency efforts face new scrutiny over pharmaceutical marketing, patient advocacy funding, PBM pricing practices and insulin costs.

International Business Times · Sep 28

Viking's Obesity Edge May Be Staying Power, Not Weight Loss

Viking Therapeutics shares jumped 36% after VK2735 maintenance data showed patients kept most weight loss on less frequent dosing, though Phase 3 results and commercial funding remain unresolved.

MarketBeat · Sep 23

Pfizer India speaks up after Karnataka FDA crackdown, says patient safety is top priority

Pfizer India has stated that patient safety and product quality are their top priorities following FDA actions. The Karnataka FDA canceled 16 drug licenses and suspended eight others due to counterfeit drugs. A raid uncovered an illegal operation repacking low-cost medicines as branded drugs, particularly Pfizer products. Pfizer has removed…

The Economic Times · Sep 23